These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 23222175)
1. Mesenchymal stem cells in organ and tissue transplantation: one for all seasons? Eggenhofer E Curr Opin Organ Transplant; 2013 Feb; 18(1):22-3. PubMed ID: 23222175 [No Abstract] [Full Text] [Related]
2. Mesenchymal stromal cells in transplantation rejection and tolerance. English K; Wood KJ Cold Spring Harb Perspect Med; 2013 May; 3(5):a015560. PubMed ID: 23637312 [TBL] [Abstract][Full Text] [Related]
3. [The role of mesenchymal stromal cells in solid organ transplantation]. Delens L; Jouret F; Detry O; Beguin Y; Krzesinski JM Rev Med Suisse; 2014 Aug; 10(439):1538, 1540-3. PubMed ID: 25272670 [TBL] [Abstract][Full Text] [Related]
4. The potential impact of the reperfusion injury on acute and chronic rejection events following organ transplantation. Land W Transplant Proc; 1994 Dec; 26(6):3169-71. PubMed ID: 7998106 [No Abstract] [Full Text] [Related]
8. Roles of toll-like receptors signaling in organ transplantation. Li T; Chen G; Zhang Z Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357 [TBL] [Abstract][Full Text] [Related]
9. Preventing rejection. Kraco K Minn Med; 2001 Dec; 84(12):32-5. PubMed ID: 11774621 [No Abstract] [Full Text] [Related]
10. The impact of free radical-mediated reperfusion injury on acute and chronic rejection events following cadaveric renal transplantation. Schneeberger H; Schleibner S; Illner WD; Messmer K; Land W Clin Transpl; 1993; ():219-32. PubMed ID: 7918155 [TBL] [Abstract][Full Text] [Related]
11. Ischemia-reperfusion-induced lung injury. de Perrot M; Liu M; Waddell TK; Keshavjee S Am J Respir Crit Care Med; 2003 Feb; 167(4):490-511. PubMed ID: 12588712 [TBL] [Abstract][Full Text] [Related]
12. [Immunosuppression after organ transplantation]. Wagner K; Erhard J Zentralbl Chir; 1992; 117(12):648-52. PubMed ID: 1285470 [TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model. Jia Z; Jiao C; Zhao S; Li X; Ren X; Zhang L; Han ZC; Zhang X Exp Eye Res; 2012 Sep; 102():44-9. PubMed ID: 22800963 [TBL] [Abstract][Full Text] [Related]
14. [Humoral immunity and kidney transplantation. Possibilities and desensitizing treatment]. Rowshani AT; Lardy NM; Surachno JS; ten Berge RJ Ned Tijdschr Geneeskd; 2009 Mar; 153(13):612-6. PubMed ID: 19408538 [No Abstract] [Full Text] [Related]
15. Immunomodulative cell therapy after solid organ transplantation: which cell type when? Dahlke MH Curr Opin Organ Transplant; 2012 Feb; 17(1):33. PubMed ID: 22227720 [No Abstract] [Full Text] [Related]
16. Immunoregulatory Cells: Can They Be Harnessed for Transplant? Pullen LC Am J Transplant; 2019 Feb; 19(2):309-310. PubMed ID: 30690909 [No Abstract] [Full Text] [Related]
17. Immunosuppressive agents in organ transplantation: past, present, and future. Hong JC; Kahan BD Semin Nephrol; 2000 Mar; 20(2):108-25. PubMed ID: 10746855 [TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived mesenchymal stem cells as immunosuppressants in liver transplantation: a review of current data. Zhang H; Chen Z; Bie P Transfus Med Rev; 2012 Apr; 26(2):129-41. PubMed ID: 22015073 [TBL] [Abstract][Full Text] [Related]
19. [The HLA system and transplantation]. Onizuka M; Naruse T; Inoko H Nihon Rinsho; 2005 Apr; 63 Suppl 4():653-8. PubMed ID: 15861724 [No Abstract] [Full Text] [Related]